肝细胞癌中的选择性自:机制,作用和治疗影响 (综述)
1Department of Plastic Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan, R.O.C.
Experimental and therapeutic medicine
|November 12, 2025
概括
选择性自在肝细胞癌 (HCC) 中起着复杂的作用,影响治疗耐药性和细胞死亡. 针对特定的自途径为HCC治疗提供了有前途的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
- 分子医学是分子医学.
背景情况:
- 选择性自,特定细胞组件的依赖溶酶体的降解,在肝细胞癌 (HCC) 中具有多方面的作用.
- 十种不同的选择性自途径涉及到HCC:线粒,溶,网膜,乳,核, ribo,脂,糖,铁素和流体.
研究的目的:
- 审查选择性自途径在肝细胞癌 (HCC) 中的多样性作用.
- 探索与HCC中这些途径相关的治疗机会和生物标志物潜力.
主要方法:
- 在HCC中选择性自途径的文献综述.
- 在HCC进展和治疗耐药性中分析了线粒细胞衰变,溶解细胞衰变,网膜细胞衰变,铁氨酸细胞衰变和脂质细胞衰变的功能.
主要成果:
- 线性食促进了治疗耐药性;食维持了 lysosomal 的恒常性.
- 网膜菌保护HCC细胞免受铁;铁蛋白菌调节铁的水平和铁的敏感性.
- 脂质会表现出双重作用,提供能量基质,同时可能抑制瘤生长.
结论:
- 选择性自途径通过抑制,激活或合成致死性在HCC中呈现治疗点.
- 策略包括将铁灭症诱导剂与自抑制剂结合起来,准像FAM134B这样的受体,调节线粒的调节器.
- 与自相关的生物标志物 (序列体1,LC-3B,贝克林-1) 可能有助于为个性化HCC治疗患者分层.
相关概念视频
Autophagy
5.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Delivery Pathways to the Lysosome
8.7K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.7K
Autophagic Cell Death
4.3K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


